Division of Pediatric Surgery, Children's Hospital Colorado, Aurora, CO, United States; Department of Surgery, University of Colorado School of Medicine, Aurora, CO, United States.
The Center for Research in Outcomes for Children's Surgery, Center for Children's Surgery, University of Colorado School of Medicine, Aurora, CO, United States.
J Pediatr Surg. 2022 Jun;57(6):1067-1071. doi: 10.1016/j.jpedsurg.2022.01.055. Epub 2022 Feb 12.
There is a paucity of data on the frequency of transfusion during pediatric surgery index cases and guidelines for pretransfusion testing, defined as type and screen and crossmatch testing, prior to operation are not standardized. This study aimed to determine the incidence of perioperative blood transfusions during index neonatal operations and identify risk factors associated with perioperative blood transfusion to determine which patients benefit from pretransfusion testing.
A retrospective review of infants who underwent index neonatal cases between 2013 and 2019 was performed. Data were collected for patients who underwent operations for Hirschsprung's disease, esophageal atresia/tracheoesophageal fistula (EA/TEF), biliary atresia, anorectal malformation, omphalocele, gastroschisis, duodenal atresia, congenital diaphragmatic hernia (non-ECMO) or pulmonary lobectomy. Infants under 6 months were included except in the case of lobectomy where infants up to 12 months were included.
Analysis was performed on 420 patients. Twenty-five (6.0%) patients received perioperative blood transfusion. Patients who received perioperative transfusion most commonly underwent EA/TEF repair. Patients who received perioperative transfusion had higher rates of structural heart disease (52.0% vs 17.7%, p<0.001), preoperative transfusion (48.0% vs 8.9%, p<0.001), and prematurity (52.0% vs 25.6%, p = 0.005). Presence of all three risk factors resulted in a 48% probability of requiring perioperative transfusion.
Blood transfusion during the perioperative period of neonatal index operations is rare. Factors associated with increased risk of perioperative transfusion include prematurity, structural heart disease, and history of previous blood transfusion.
III.
小儿外科手术中输血的频率数据很少,且手术前的输血检测指南(定义为血型和交叉配血检测)也没有标准化。本研究旨在确定新生儿手术中围手术期输血的发生率,并确定与围手术期输血相关的风险因素,以确定哪些患者受益于输血前检测。
对 2013 年至 2019 年间接受新生儿手术的患儿进行回顾性分析。对接受巨结肠、食管闭锁/气管食管瘘(EA/TEF)、胆道闭锁、肛门直肠畸形、脐膨出、腹裂、十二指肠闭锁、先天性膈疝(非 ECMO)或肺叶切除术的患儿进行了数据收集。纳入了 6 个月以下的患儿,但肺叶切除术的患儿纳入了 12 个月以下的患儿。
对 420 例患儿进行了分析。25 例(6.0%)患儿接受了围手术期输血。接受围手术期输血的患儿最常见的手术是 EA/TEF 修复。接受围手术期输血的患儿结构性心脏病发生率更高(52.0% vs 17.7%,p<0.001)、术前输血率更高(48.0% vs 8.9%,p<0.001)、早产率更高(52.0% vs 25.6%,p=0.005)。存在所有三种风险因素会导致 48%的患儿需要围手术期输血。
新生儿手术围手术期输血较为罕见。增加围手术期输血风险的因素包括早产、结构性心脏病和既往输血史。
III 级。